Always seek the advice of your healthcare provider first
By understanding how well your patients manage oxidative stress, you can create personalized treatment options that cater to their needs and help them lead longer, healthier lives
In the published Phase 1/2 data, the clinical signature is consistent with that pharmacology: strong appetite suppression (GLP-1R-mediated), preserved glycemic control and improved tolerability versus pure GLP-1 agonists at equivalent weight-loss doses (GIPR-mediated), and meaningful thermogenic/fat-oxidation contribution above and beyond dual GLP-1/GIP activity (GCGR-mediated)
J Neurophysiol
After four weeks at 0.25 mg, doses increase in steps every four weeks, following the pattern below
One reviewer calls them their go-to for backpacking, writing, "I usually don't like products with stevia, but these don't taste like they have it I've tried 5-6 similar products and keep coming back to these